Manus Bio is awarded a Phase I SBIR Grant from the National Science Foundation for the biosynthesis of a potent natural acaricide
CAMBRIDGE, Mass., July 1, 2016 - Manus Bio, a global leader in the production of plant-based ingredients, announced today that it has been awarded a prestigious National Science Foundation grant under the Small Business Innovation Research (SBIR) program. This Phase I award ($225,000) supports the development of an advanced fermentation process for the economical and sustainable production of a highly potent natural acaricide. The full project abstract can be found at https://www.nsf.gov/awardsearch/showAward?AWD_ID=1621420.
About Manus Bio
Manus Bio is a global leader in the use of advanced fermentation technology for manufacturing complex, bioactive natural products as flavors, fragrances, food ingredients, biopesticides, and pharmaceuticals. The core team and technology are from MIT, and the company is headquartered in Cambridge, MA, USA. For more information, visit www.manusbio.com.